Artwork

Contenuto fornito da BioTalent Canada. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da BioTalent Canada o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Player FM - App Podcast
Vai offline con l'app Player FM !

Commercializing the Academic Research – and Managing Substantial Growth

36:46
 
Condividi
 

Manage episode 360963687 series 3398740
Contenuto fornito da BioTalent Canada. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da BioTalent Canada o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.

Applied Pharmaceutical Innovation (API) was launched to solve a big challenge. Commercialization within the life sciences. There’s a general lack of understanding of the technical and scientific capacity needed for a life sciences company to commercialize in Canada. API sought to fix that.

Part incubator, part R&D, API helps companies scale up here in Canada where they would normally have to invest tens of millions of dollars just to build out their infrastructure. And the model is working, with growth forecast to see 60 staff currently blossom to 150 in the next 18 months.

In addition, the Government of Canada recently made an $80.5 million investment in a key project API is involved in.

But that success itself brings many challenges. How is API handling those?

Guest: Andrew MacIsaac, CEO Applied Pharmaceutical Innovation (API)

Website: appliedpharma.ca

LinkedIn: https://www.linkedin.com/company/applied-pharmaceutical-innovation

Twitter: @api_applied

BioTalent Canada Website

See the latest news on our website

Contact

BioTalent Canada by email

  continue reading

12 episodi

Artwork
iconCondividi
 
Manage episode 360963687 series 3398740
Contenuto fornito da BioTalent Canada. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da BioTalent Canada o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.

Applied Pharmaceutical Innovation (API) was launched to solve a big challenge. Commercialization within the life sciences. There’s a general lack of understanding of the technical and scientific capacity needed for a life sciences company to commercialize in Canada. API sought to fix that.

Part incubator, part R&D, API helps companies scale up here in Canada where they would normally have to invest tens of millions of dollars just to build out their infrastructure. And the model is working, with growth forecast to see 60 staff currently blossom to 150 in the next 18 months.

In addition, the Government of Canada recently made an $80.5 million investment in a key project API is involved in.

But that success itself brings many challenges. How is API handling those?

Guest: Andrew MacIsaac, CEO Applied Pharmaceutical Innovation (API)

Website: appliedpharma.ca

LinkedIn: https://www.linkedin.com/company/applied-pharmaceutical-innovation

Twitter: @api_applied

BioTalent Canada Website

See the latest news on our website

Contact

BioTalent Canada by email

  continue reading

12 episodi

Tutti gli episodi

×
 
Loading …

Benvenuto su Player FM!

Player FM ricerca sul web podcast di alta qualità che tu possa goderti adesso. È la migliore app di podcast e funziona su Android, iPhone e web. Registrati per sincronizzare le iscrizioni su tutti i tuoi dispositivi.

 

Guida rapida